BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27320588)

  • 1. Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report.
    Kang GW; Hong HL; Lee IH; Ahn KS; Kim JD; Choi DL
    Transplant Proc; 2016 May; 48(4):1208-11. PubMed ID: 27320588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytomegalovirus meningoencephalitis in a diffuse large B-cell lymphoma patient undergoing salvage chemotherapy].
    Yoshida K; Kosako H; Yamashita Y; Kobata H; Oiwa T; Hosoi H; Murata S; Mushino T; Nishikawa A; Araoka H; Sonoki T; Tamura S
    Rinsho Ketsueki; 2019; 60(2):124-129. PubMed ID: 30842379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
    Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint MT; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Transplantation; 1996 Aug; 62(3):376-80. PubMed ID: 8779686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy.
    Anders HJ; Weiss N; Bogner JR; Goebel FD
    J Infect; 1998 Jan; 36(1):29-33. PubMed ID: 9515665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Primary Cytomegalovirus Infection After Deceased Donor Kidney Transplant: Ganciclovir Susceptibility of Human Cytomegalovirus With UL97 D605E Mutation: A Case Report.
    Nawashiro Y; Shiraki K; Yamamoto S; Takizawa K; Sasada Y; Suehiro M; Miura K; Hattori M; Daikoku T; Hisano M
    Transplant Proc; 2018 Dec; 50(10):3932-3936. PubMed ID: 30577289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.
    Julin JE; van Burik JH; Krivit W; Webb C; Holman CJ; Clark HB; Balfour HH
    Transpl Infect Dis; 2002 Dec; 4(4):201-6. PubMed ID: 12535263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature.
    Baghban A; Malinis M
    J Neurol Sci; 2018 May; 388():28-36. PubMed ID: 29627026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS.
    Enting R; de Gans J; Reiss P; Jansen C; Portegies P
    Lancet; 1992 Aug; 340(8818):559-60. PubMed ID: 1354319
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E; Kallas WM; Fishman JA
    Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor].
    Fujisaki T; Gondo H; Uchida N; Matsuo I; Takenaka K; Tanimoto K; Otsuka T; Minematsu T; Minamishima Y; Niho Y
    Rinsho Ketsueki; 1997 Feb; 38(2):142-5. PubMed ID: 9059069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
    Minces LR; Nguyen MH; Mitsani D; Shields RK; Kwak EJ; Silveira FP; Abdel-Massih R; Pilewski JM; Crespo MM; Bermudez C; Bhama JK; Toyoda Y; Clancy CJ
    Antimicrob Agents Chemother; 2014; 58(1):128-35. PubMed ID: 24145525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection.
    Avery RK; Arav-Boger R; Marr KA; Kraus E; Shoham S; Lees L; Trollinger B; Shah P; Ambinder R; Neofytos D; Ostrander D; Forman M; Valsamakis A
    Transplantation; 2016 Oct; 100(10):e74-80. PubMed ID: 27495775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
    Manfredi R; Mastroianni A; Coronado OV; Chiodo F
    Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset of ganciclovir-resistant cytomegalovirus infection in a lung-transplant recipient.
    Chen F; Bando T; Hanaoka N; Fukuse T; Hasegawa S; Wada H
    Jpn J Thorac Cardiovasc Surg; 2005 Oct; 53(10):562-4. PubMed ID: 16279588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cytomegalovirus infection after living donor liver transplantation.
    Yamanouchi K; Eguchi S; Takatsuki M; Kamohara Y; Hidaka M; Miyazaki K; Inokuma T; Tajima Y; Kanematsu T
    Hepatogastroenterology; 2012; 59(113):231-4. PubMed ID: 22251542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review.
    Czarnecka P; Czarnecka K; Tronina O; Durlik M
    Transplant Proc; 2018 Dec; 50(10):4015-4022. PubMed ID: 30577306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.